Clinical Trial Update: Efficacy of Low Dose Sugammadex in Reversal of NMB in Laparoscopic Barbaric Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial update showing the efficacy of a low-dose sugammadex regimen to reverse neuromuscular blockade in bariatric surgery patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Assiut University | Conditions: Bariatric Patients | Phase 3 | Status: COMPLETED